Physician profile
Bryan W Ming
NPI 1548540792
$80,820.16
in general payments reported to CMS, 2019-2025
11 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,193 · 2020: $325 · 2021: $11K · 2022: $9,483 · 2023: $12K · 2024: $15K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Travel and Lodging: $5,744 · Food and Beverage: $3,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,325.00 |
| Travel and Lodging | $5,743.92 |
| Food and Beverage | $3,797.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $74,776.45 | 2019-2025 | Variax, Gamma, Axsos |
| Medical Device Business Services, INC. | $2,364.55 | 2024 | Na |
| Smith+Nephew, INC. | $1,761.18 | 2019-2024 | Trigen Intertan, Trigen, Evos Mini |
| Encore Medical, LP | $761.34 | 2024 | Djo Surgical |
| Depuy Synthes Sales INC. | $644.10 | 2019-2025 | Na, Tfn-Advance, Lcp |
| Nuvasive Specialized Orthopedics, INC. | $204.96 | 2023 | Precice Intramedullary Limb Lengthening System |
| Zimmer Biomet Holdings, INC. | $198.54 | 2019 | |
| Globus Medical, INC. | $49.95 | 2023 | Proximal Tibia Plate |
| Acera Surgical, INC. | $28.71 | 2025 | Restrata Wound Matrix |
| Becton, Dickinson and Company | $20.43 | 2024 | |
| Orthofix Medical, INC. | $9.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Ming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.